Cancer is one of the most prevalent diseases in society today as well as in history. This illness can manifest within the human body in a number of different organs. Just about everyone has been affected by this devastating disease in some form or another, but over the past 16 years, the fight against cancer is looking much more promising thanks to breakthrough therapies. Seattle Genetics is one of the leading organizations that specialize in the development and commercialization of these advanced therapies. Since it’s inception back in 1998, the organization has grown dramatically into the powerhouse of today. There are more than 800 employees under it’s huge umbrella and Seattle Genetics produces some of the best cancer treatments in the world.
For any great company/business there has to be great leadership and Clay Siegall fits the bill perfectly. This guy is worth his weight in gold thanks to his broad educational background, persistence, and passion. Siegall is known by many as a man of many acts. He has the label of being an entrepreneur, investor, author, scientist, guest speaker, and doctor. His resume of success span over decades while working with GlaxoSmithKline, The National Cancer Institute, and The National Institute of Health. Thanks to Dr. Siegall, Seattle Genetics is the leading cancer research organization in the world as it’s stock prices has risen dramatically over half a decade. The guy is a natural philanthropist as well because he does everything in his power to save lives. Dr. Siegall has also raised $1.2 Billion through public and private funding.
As of 2016, Seattle Genetics has grown to be one of the fastest growing companies in the country, stated by Forbes. With the abundance of many newer drugs in it’s pipeline, the company will be looking to fill the void by hiring another 200 employees. All in all, this is the future of cancer research and Dr. Clay Siegall is stiring the pot of success.